Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers

NCT05451667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Tolerability

Interventions

DRUG: YJ001 for Spray Use
DRUG: Placebo of YJ001 for Spray Use

Sponsor

Yuejia Pharmaceuticals (USA), Inc.

Collaborators

[object Object]